Skip to content

Total debt at other companies

IAR
Integra LifeSciencesIART
$1.98B+3.2%
MiMedx Group logo
MiMedx GroupMDXG
$17.59M-5.7%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$237.5M+32.3%
Bioventus logo
BioventusBVS
$288.42M-21.2%
Artivion logo
ArtivionAORT
$258.16M-28.8%
Axogen logo
AxogenAXGN
$20.64M-69.8%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s total debt?
Organogenesis Holdings Inc. (ORGO) reported total debt of $39.42M in Q1 2026.
How has Organogenesis Holdings Inc.'s total debt changed year-over-year?
Organogenesis Holdings Inc.'s total debt increased by 24.8% year-over-year, from $31.58M to $39.42M.
What is the long-term trend for Organogenesis Holdings Inc.'s total debt?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s total debt has grown at a 3.4% compound annual growth rate (CAGR), from $77.66M to $91.57M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.